Literature DB >> 32690140

The virome in hematology-Stem cell transplantation and beyond.

Jérôme Legoff1, David Michonneau2, Gérard Socie3.   

Abstract

The virome has been recently studied in hematology and mostly in the setting of allogeneic hematopoietic stem cell transplantation. However, in hematology (as in the setting of nonhematological disorders) the study of the microbiome (that indeed includes the virome) is a growing field. The overall field is moving beyond species catalogue to the understanding of the complex ecological relationship that microbes have with each other and with their host. Here we review the existing literature on the virome in transplant recipients and in other settings, and discuss potential applications of the virome study in hematology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Keywords:  GVHD; Hematopoietic stem cell transplantation; Immune deficiency; Virome

Mesh:

Year:  2020        PMID: 32690140     DOI: 10.1053/j.seminhematol.2020.05.001

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  3 in total

Review 1.  Human pegivirus infection after transplant: Is there an impact?

Authors:  Anna Mrzljak; Bojana Simunov; Ivan Balen; Zeljka Jurekovic; Tatjana Vilibic-Cavlek
Journal:  World J Transplant       Date:  2022-01-18

2.  Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.

Authors:  Francesca Lorentino; Elisabetta Xue; Sara Mastaglio; Fabio Giglio; Daniela Clerici; Francesca Farina; Simona Piemontese; Alessandro Bruno; Lorenzo Lazzari; Annalisa Ruggeri; Elena Guggiari; Francesca Lunghi; Andrea A Assanelli; Sarah Marktel; Magda Marcatti; Matteo G Carrabba; Massimo Bernardi; Consuelo Corti; Jacopo Peccatori; Fabio Ciceri; Raffaella Greco; Maria Teresa Lupo-Stanghellini
Journal:  Blood Adv       Date:  2022-05-24

Review 3.  The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation.

Authors:  Tirthankar Sen; Rajkumar P Thummer
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.